Stay updated on Lebrikizumab in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lebrikizumab in Atopic Dermatitis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the ClinicalTrials.gov error page, announcing a terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-22T13:48:25.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-15T13:42:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T14:07:56.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study content with an access-restricted page. The new screen includes a 403 message and a Home link, indicating that the detailed study information is not currently accessible.
    Difference
    21%
    Check dated 2026-09-24T18:15:50.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.6 to v3.7.0, signaling a new build; no study details are altered.
    Difference
    0.0%
    Check dated 2026-09-17T22:03:22.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    This update adds an NIH grant/contract line to the study's identifiers, indicating funding support for the trial.
    Difference
    0.0%
    Check dated 2026-08-27T18:39:27.000Z thumbnail image

Stay in the know with updates to Lebrikizumab in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lebrikizumab in Atopic Dermatitis Clinical Trial page.